Genetic changes to avian influenza viruses have led to spread among many wild species, creating an uncontrollable global outbreak.

Highly pathogenic avian influenza (HPAI) H5N1 activity has intensified globally since 2021, increasingly causing mass mortality in wild birds and poultry and incidental infections in mammals.

European health ministers agreed on a target of vaccinating 75% of older people in 2009 ‒ almost all countries are still falling short.

On February 2023, the French National Authority for Health (HAS) recommended extending flu shots to children aged 2-17 years without comorbidities.

Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and impairs hippocampal responses and memory. These findings provide a possible explanation for neurocognitive symptoms associated with viral persistence in Long COVID.

Since SARS-CoV-2 BA.5 (Omicron) emerged and spread in 2022, Omicron lineages have markedly diversified.

In the last three years, extensive research has demonstrated the safety and efficacy of COVID-19 vaccines. These vaccines have played a critical role in reducing mortality and hospitalization rates.

On 11 October 2023, for the fourth edition of EU Flu Day, around 100 people gathered in person and online to participate in the event at the European Parliament

Current vaccines should be tailored to combat future SARS-CoV-2 variants.

The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle.

Steering Group on Influenza Vaccination releases on the EU Flu Day a set of Policy Recommendations for the EU and national governments to expand influenza vaccine uptake.

An overview of vaccination recommendations for 2021-22 and coverage rates for the 2018–19 to 2020–21 influenza seasons.